Active Biotech
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
ACTI | ST
Overview
Corporate Details
- ISIN(s):
- SE0001137985 (+2 more)
- LEI:
- 549300OJ44CLMRU8YE43
- Country:
- Sweden
- Address:
- Scheelevägen 22, 223 63 Lund
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Active Biotech is a biotechnology company focused on developing pharmaceutical products for medical areas where the immune system is significant, primarily cancer and inflammatory diseases. The company leverages its portfolio of compounds to create novel treatments for specialist indications with high unmet medical need. Its development pipeline includes fully owned projects like tasquinimod for hematological cancers (multiple myeloma, myelofibrosis) and laquinimod for inflammatory eye disorders (non-infectious uveitis). It also has licensed projects, such as naptumomab for solid tumors, which is developed in partnership with NeoTX.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-26 10:38 | Swedish | 10.7 KB | |||
| 2025-11-25 08:30 |
Idag inleds teckningsperioden i Active Biotechs företrädesemission
|
Swedish | 115.3 KB | ||
| 2025-11-25 08:30 |
The subscription period in Active Biotech’s rights issue begins today
|
English | 117.9 KB | ||
| 2025-11-21 10:23 | Swedish | 10.7 KB | |||
| 2025-11-20 15:45 |
Active Biotech publishes information document regarding rights issue
|
English | 114.3 KB | ||
| 2025-11-20 15:45 |
Active Biotech offentliggör informationsdokument avseende företrädesemission
|
Swedish | 110.3 KB | ||
| 2025-11-20 10:37 | Swedish | 10.6 KB | |||
| 2025-11-19 12:00 |
Extra bolagsstämma i Active Biotech AB
|
Swedish | 72.7 KB | ||
| 2025-11-19 12:00 |
Extraordinary General Meeting of Active Biotech AB
|
English | 78.5 KB | ||
| 2025-11-19 10:31 | Swedish | 10.6 KB | |||
| 2025-11-12 10:13 | Swedish | 10.5 KB | |||
| 2025-11-06 08:30 | Swedish | 509.2 KB | |||
| 2025-11-06 08:30 | English | 503.0 KB | |||
| 2025-10-28 09:32 | Swedish | 10.6 KB | |||
| 2025-10-24 10:03 | Swedish | 10.6 KB |
Automate Your Workflow. Get a real-time feed of all Active Biotech filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Active Biotech
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Active Biotech via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-10 | Peter Thelin | Other | Other | 164,638,960 | 8,231,948.00 SEK |
| 2024-11-15 | Hans Kolam | Other | Other | 19,800 | 990.00 SEK |
| 2022-09-05 | Aleksandar Danilovski | Other | Buy | 26,672 | 26,672.00 SEK |
| 2022-04-22 | Helen Tuvesson Andersson | Other | Buy | 2,665 | 3,102.86 SEK |
| 2022-04-21 | Helen Tuvesson Andersson | Other | Buy | 37,335 | 41,767.60 SEK |
| 2021-06-17 | Aleksandar Danilovski | Other | Buy | 40,000 | 60,000.00 SEK |
| 2021-06-01 | Michael Shalmi | Other | Buy | 175,000 | 259,437.50 SEK |
| 2021-04-27 | Helen Tuvesson Andersson | Other | Buy | 10,411 | 16,657.60 SEK |
| 2021-04-27 | Helena Eriksson | Other | Buy | 10,000 | 14,460.00 SEK |
| 2021-04-27 | Helen Tuvesson Andersson | Other | Buy | 1,041 | 1,665.60 SEK |
Peer Companies
